Monte Rosa Therapeutics, Inc.

NASDAQ:GLUE

4.79 (USD) • At close April 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income 13.437-23.859-30.31-31.968-33.252-34.884-35.178-32.038-30.782-27.318-26.469-23.932-23.44-19.837-18.405-12.276-19.656-6.557-5.364-4.302
Depreciation & Amortization 2.0612.1032.061.8971.8461.8341.3911.1511.071.0330.8890.7530.8090.5820.4670.2740.2230.1710.0720.071
Deferred Income Tax 0000-1.998000000000000-0.00100
Stock Based Compensation 4.4694.2824.5024.8734.0744.4684.1533.9743.3263.2142.8732.2511.8562.0731.0190.2520.2010.0450.0970.011
Change In Working Capital 109.65115.823-2.925-12.89857.7034.3735.7484.6422.0731.2661.212-6.6856.599-0.6253.337-3.0252.978-0.550.9830.844
Accounts Receivables 0.4228.91-9.327-0.01-00.375-0.1952.053-0-00000000000
Change In Inventory 00000-0.3750.195-2.053000000000000
Change In Accounts Payables 13.308-2.380.394-5.075.7680.686-1.0020.3060.1551.648-0.363-2.1844.74-4.251-0.289-0.9061.929-0.6521.9840.174
Other Working Capital 95.9219.2936.008-7.81851.9353.6876.754.3361.918-0.3821.575-4.5011.8593.6263.626-2.1191.0490.102-1.0010.67
Other Non Cash Items -0.696-19.34316.46113.6781.261-0.497-1.438-1.1350.3521.2050.9940.2090.0040.0132.2420.967.680.0011.9840.174
Operating Cash Flow 128.922-20.994-27.767-38.16529.634-24.706-25.324-23.406-23.961-20.6-20.501-27.404-14.172-17.794-13.582-13.815-8.574-6.891-4.212-3.376
Investing Activities:
Investments In Property Plant And Equipment -0.183-0.399-2.022-1.384-1.689-1.659-6.512-9.181-7.271-1.4-2.553-1.687-3.059-1.755-2.701-2.217-1.186-0.93-1.26-0.013
Acquisitions Net 0000-0.016-0.0370.0620.1310.047-0.0160.0120.1250.0120.067000000
Purchases Of Investments -67.961-32.373-73.959-56.068-27.514-7.813-0.062-67.824-94.368-59.395-51.696-178.95800000000
Sales Maturities Of Investments 37.24870.52114.82367.30543.545.12597.33147.790.340000000000
Other Investing Activites 00-59.13611.2370.0160.0370.062-0.131-0.0470.031-0.0120.1250.0120.067000000
Investing Cash Flow -30.89637.749-61.1589.85314.29735.62818.5520.326-53.93929.489-14.249-180.52-3.047-1.688-2.701-2.217-1.186-0.93-1.26-0.013
Financing Activities:
Debt Repayment 00000000000000000000
Common Stock Issued -47.001098.0230.24625.1731.1011.20.01820.055-0.2170.0960.153-0.13531.0110142.7690000
Common Stock Repurchased 0000000000000.23100-0.23100-0.1780
Dividends Paid 00000000000000000000
Other Financing Activities 47.6090.65698.0230.24625.1731.1011.20.0180.379-0.2170.0960.153-0.135-1.555205.472142.769-0.0147.74812.3220
Financing Cash Flow 0.6080.01598.0230.24625.1731.1011.20.01820.434-0.2170.0960.153-0.13529.456205.472142.769-0.0147.74812.3220
Other Information:
Effect Of Forex Changes On Cash 0000-0.058000000000000000
Net Change In Cash 98.63416.779.095-28.34969.04612.023-5.574-3.062-57.4668.672-34.654-207.771-17.3549.974189.189126.737-9.7739.9276.85-3.389
Cash At End Of Period 229.117130.483108.84799.752128.10163.57751.55457.12860.19117.656108.984143.638351.409368.763358.789169.642.86352.63312.7065.856